Abstract:Background Blood transfusion therapy is extremely important for certain neonatal diseases, but the threshold for neonatal blood transfusion is not the same in different countries. Until now, clinical studies to determine the suitable threshold for newborns in China are lacking. Therefore, it is of high importance to establish a multi-center cohort study to explore appropriate transfusion thresholds for newborns in China. Methods This retrospective cohort study investigated neonatal blood transfusion therapy administered from January 1, 2017 to June 30, 2018, with the aim of evaluating the effect of restricted and nonrestricted blood transfusion on neonatal health. The subjects were enrolled in 46 hospitals in China. A total of 5669 neonatal cases were included in the study. Clinical diagnosis and transfusion treatment of these neonates were collected and the data were retrospectively analyzed. The neonates were followed up 1 week and 1 month after leaving the hospital. The newborns’ and their mothers’ data were collected containing 280 variables in the database. The primary outcome of the study was mortality, and the secondary outcomes were complications, hospital stays, NICU hospital stays and hospital costs. Results Results from the < 1500 g group showed that there was a higher mortality rate in the restricted transfusion group (11.41%) when compared with the non-restricted transfusion group (5.12%) ( P = 0.000). Among the secondary outcomes, the restricted transfusion group had fewer costs. Results from the 1500-2500 g group showed that the mortality rates of the restricted and non-restricted transfusion groups were 3.53% and 4.71%, respectively, however there was no statistical significance between the two groups ( P = 0.345). Among the secondary outcomes, the restricted transfusion group had fewer hospital stays, NICU hospital stays and hospital costs. The incidence of necrotizing enterocolitis was lower in the restricted transfusion group (OR, 2.626; 95% confidence interval [CI], 1.445 to 4.773; P = 0.003). The results from the ≥ 2500 g restricted transfusion group suggested that the mortality rate of (3.02%) was significantly lower than that of non-restricted transfusion group (9.55%) ( P = 0.000). Among the secondary outcomes, the restricted transfusion group had fewer hospital stays and hospital costs. The incidence of retinopathy of prematurity was lower in the restricted transfusion group (OR, 4.624; 95% confidence interval [CI], 2.32 to 9.216; P = 0.000). Conclusions Current transfusion protocols for newborns weighing less than 1500 g may be inappropriate and lead to higher mortality. The current transfusion threshold performed better for the other two weight groups.

Investigation and factors analysis of 331 cases of transfusion-related adverse reactions in pediatric patients

Investigation of the clinical features and influencingfactors of adverse transfusion reactions

Clinical Analysis of 159 Times Acute Transfusion Reaction in Single Center.

Analysis of pediatric adverse reactions to transfusions

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

Adverse transfusion reactions in transfused children

Platelet concentrate and type II IL-1 receptor are risk factors for allergic transfusion reactions in children

Correlation and Regression Analysis Applied for Types and Number of Blood Transfusions Versus Transfusions Induced ADR Among Pediatric Haemato-Oncology and Thalassemia Patients

Associations between transfusion reactions and thromboembolism development in blood‐transfused patients: A retrospective cohort study

Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients

Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort

Research progress on febrile non-hemolytic transfusion reaction: a narrative review

Increased platelet to red blood cell transfusion ratio associated with acute kidney injury in children with life‐threatening bleeding

Transfusion‐induced Platelet Antibodies and Regulatory T Cells in Multiply Transfused Patients

Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes

Factors Associated with Red Blood Cell Transfusion among Hospitalized Patients: a Cross-Sectional Study.

Blood donor, component, and recipient‐specific factors associated with venous thromboembolism in transfused hospitalized adult patients: Data from the recipient epidemiology and donor evaluation Study‐III (REDS‐III)

Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction

Responsiveness to Platelet Transfusions in Pediatric Patients with Thrombocytopenia: Incidence, Clinical Variables

Clinical Application of Transfusion of Leukocyte Filtration Blood Prevent Febrile Nonhemolytic Transfusion Reactions

Retrospective Cohort Study of Neonatal Blood Transfusion in China